Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02881515 · ClinicalTrials.gov registry record · NA
Adverse Neurogenic Actions of Dietary Salt
A NA study of Blood Pressure, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT02881515: Completed NA study of Blood Pressure, sponsored by University of Delaware.
NCT02881515 is a NA study of Blood Pressure that has completed, run by University of Delaware. The registered enrollment target is 77 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02881515, a NA study of Blood Pressure, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
Excess dietary salt increases the risk for cardiovascular events, even in people that are not hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and sympathetic nervous system responses to various perturbations and increases blood pressure variability. This proposal will examine the effects of low, medium, and high salt diets on cardiovascular reactivity and blood pressure variability.
Primary Outcome
Standard deviation of systolic blood pressure over 24 hours (mmHg)
Conditions Studied
Interventions
- OTHER Low Sodium Diet
- OTHER Medium Sodium Diet
- OTHER High Sodium Diet
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-11-22 |
| Phase | NA |
What the finished NCT02881515 record still lists
NCT02881515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Low Sodium Diet is the first listed.
NCT02881515 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT02881515 about?
NCT02881515 is a clinical study titled "Adverse Neurogenic Actions of Dietary Salt". Excess dietary salt increases the risk for cardiovascular events, even in people that are not hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and sympathetic nervous system responses to various perturbations and increases blood pressure variability. This prop...
What is the current status of trial NCT02881515?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2016-04. Estimated completion is 2022-11-22.
What conditions does trial NCT02881515 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT02881515?
The interventions under investigation include: Low Sodium Diet (OTHER), Medium Sodium Diet (OTHER), High Sodium Diet (OTHER).
Who is sponsoring clinical trial NCT02881515?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02881515 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02881515's enrollment target sits among peer trials
77 48th of 101 higher than 54 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia